Making the paper: Roger Reeves.

The article offers information on the study conducted to determine the possible therapeutic role of Down syndrome in cancer prevention. Geneticists at the Johns Hopkins University School of Medicine in Baltimore, Maryland conducted an epidemiological study to prove the claim that person with Down syndrome are less likely to develop solid tumours. The result of the study showed that high proportion of intestinal cancers reduced tumour formation by half. The study is important in developing pharmacological approaches to help people with Down syndrome to live even fuller.